A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA

Human Gene Therapy

Volumn 9, Issue 16, 1998, Pages 2407-2425

  Wong Staal, Flossie ^a   Poeschla, Eric M ^a   Looney, David J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; RIBOZYME; VIRUS RNA; VIRUS VECTOR;

ARTICLE; AUTOTRANSPLANTATION; CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHASE 1 CLINICAL TRIAL; RETROVIRUS; RNA CLEAVAGE; T LYMPHOCYTE;

EID: 0032211255     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.16-2407     Document Type: Article

References (14)

1. Piot P, Laga M. Epidemiology of AIDS in the developing world. In Broder S, Merigan TC, Bolognesi D, eds. Textbook of AIDS Medicine. Baltimore: William and Wilkins, 1994:109-132.
2. The HIV/AIDS Pandemic: 1993 Overview (document WHO/GPA/CNP/EVA/93.1, Global Program on AIDS, Geneva, 1993.
3. Merson MH. Slowing the spread of HIV: agenda for the 1990s. Science 1993;260:1266-1268.
4. Anderson RM, May RM, Boily MC, Garnett GP, Rowley JT. The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature, 1991 Aug 15, 352(6336):581-9.
5. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr. Feinberg JE, Balfour HH Jr, Deyton LR, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team [see comments]. New England Journal of Medicine, 1997 Sep 11, 337(11):725-33.
6. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [see comments]. New England Journal of Medicine, 1997 Sep 11, 337(11):734-9.
7. Cohen J. The daunting challenge of keeping HIV suppressed [news]. Science, 1997 Jul 4, 277(5322):32-3.
8. Stephen Deeks (University of California San Francisco), Richard D'Aquila (Harvard Medical School), Calvin J. Cohen (Brown University). 37th Intersciences Conference on Antimicrobials and Chemotherapeutics. Toronto, CA, September 28-30 1997.
9. Wong-Staal F. Human immunodeficiency viruses and their replication. In Virology, Fields BN (ed), 1990, Raven Press, New York.
10. Yu M, Poeschla E, Wong-Staal F. Progress towards gene therapy for HIV infection. Gene Therapy 1:13-26. (1994).
11. Poeschla E, Wong-Staal F. Gene therapy and HIV Disease. AIDS Clin Rev 1995/96. Volberding P, Jacobsen M (ed.). pp. 1-45.
12. Fauci AS. Multifactorial nature of HIV Disease: implications for therapy. Science 262:1011-1018 (1993).
13. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, TennerRacz K, Haase AT. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359-362 (1993).
14. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358 (1993).